Akebia Therapeutics Inc (AKBA) FY2025Q3 Earning Prediction

11/10 05:00:00

Pre-Market

Akebia Therapeutics Inc (AKBA) is set to release its earnings performance on 11/10 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 56.42M and an earnings per share (EPS) of 0.00 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

56.42M

58.77M

+4.16%

EPS-

0.00

AI Summary

Report

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

AKBA Transcript

Akebia Therapeutics, Inc. (AKBA) Q3 2025 Earnings Call Transcript

Positive11-10

The earnings call highlights significant patient access expansion for Vafseo, improved financial performance, and positive physician feedback on clinical data. Although there are operational challenges, strategies are in place to address them. The Q&A reveals enthusiasm for the product and progress in partnerships, despite some uncertainties. Overall, the company's optimistic revenue growth expectations, patient access expansion, and improved net income suggest a positive stock price movement over the next two weeks.

Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Neutral9-5

Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call Transcript

Unknown8-7

The earnings call presented strong financial performance with record revenues and improved net income, which is positive. However, concerns about regulatory risks, generic competition, and economic pressures in the dialysis market were highlighted, which could impact future growth. The Q&A revealed uncertainties about trial timelines and competitive dynamics. Despite positive earnings, these risks and uncertainties balance the sentiment, leading to a neutral prediction for the stock price over the next two weeks.

Akebia Therapeutics at H.C. Wainwright Conference: Vafseo’s Strategic Launch

Neutral5-20

AKBA Report

Akebia Therapeutics, Inc. 10-Q

10-Q

2025-08-07

Akebia Therapeutics, Inc. 10-Q

10-Q

2024-11-07

Akebia Therapeutics, Inc. 10-Q

10-Q

2024-05-09

Akebia Therapeutics, Inc. 10-K

10-K

2024-03-14

Frequently Asked Questions

What is the Akebia Therapeutics Inc FY2025Q3 Earnings Release Date and Time?

Akebia Therapeutics Inc (AKBA) is scheduled to release its FY2025Q3 earnings report onNov 10, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Akebia Therapeutics Inc FY2025Q3 Revenue and EPS?

Analysts' consensus predicts 56.42M in revenue and an EPS of 0.00 for Akebia Therapeutics Inc's FY2025Q3.

What Does Intellectia's AI Predict for Akebia Therapeutics Inc FY2025Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forAkebia Therapeutics Inc's FY2025Q3 earnings, with a prediction date of Nov 10, 2025. Akebia Therapeutics Inc

How Can I Use This Earnings Prediction to Trade AKBA Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 10, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Akebia Therapeutics Inc FY2025Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!